DNTH

Dianthus Therapeutics, Inc. - Common Stock (DNTH)

About Dianthus Therapeutics, Inc. - Common Stock (DNTH)

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Details

Daily high

$21.96

Daily low

$20.37

Price at open

$20.78

52 Week High

$32.27

52 Week Low

$13.36

Market cap

702.6M

Dividend yield

0.00%

Volume

286,778

Avg. volume

438,466

P/E ratio

-8.42

Dianthus Therapeutics, Inc. - Common Stock News